Shatavari vs Maca: Hormones, Menopause, Libido & Energy Compared

Shatavari and maca come from completely different traditions, yet they are increasingly sold for the same goals: menopause, libido, energy and “hormone balance.”

Shatavari—Asparagus racemosus—comes from Ayurveda and has traditionally been associated with women's reproductive wellness.

Maca—Lepidium meyenii—is an Andean root traditionally consumed as a food and is commonly marketed for vitality and sexual wellbeing.

Until recently, both had relatively limited clinical evidence.

That picture is changing.

Several new randomized Shatavari studies published between 2024 and 2026 now provide direct human data for perimenopausal symptoms, menopause and female sexual function. Maca still has interesting evidence, but much of its menopause literature remains based on small studies conducted more than a decade ago.

That does not make Shatavari a proven hormone treatment—but it changes the comparison.

Key Takeaways

Shatavari vs Maca: What Are They?

Shatavari is the root of Asparagus racemosus.

It has a long history in Ayurveda and contains steroidal saponin compounds often referred to collectively as shatavarins.

Maca is Lepidium meyenii, a root vegetable from the high Andes of Peru.

It belongs to the Brassicaceae family—the same broad botanical family as cabbage and broccoli.

This matters because “women's herb” is a marketing category, not a chemical category.

Shatavari and maca contain completely different compounds and should not be expected to produce the same physiological effects.

Which Has Better Evidence for Menopause?

This is where the comparison has changed significantly.

Shatavari now has multiple modern randomized trials.

A randomized, double-blind, multicentre trial involving 70 women found a Shatavari formulation improved several menopausal symptoms—including hot flashes, night sweats, insomnia, anxiety and vaginal dryness—more than placebo. 

A newer randomized double-blind study screened 120 women with perimenopausal symptoms and randomized 80 women to Shatavari root extract or placebo.

Participants received 300 mg once daily for eight weeks.

Among the 73 participants completing the study, Shatavari improved Menopause Rating Scale outcomes, perceived stress and several quality-of-life measures, with hot flashes showing a significant between-group improvement.

The recent Shatavari perimenopause randomized trial is important because it used validated symptom scales rather than simply asking participants whether they “felt more balanced.” 

Another 2025 randomized study evaluated standardized Shatavari extracts over 24 weeks in postmenopausal women and reported favourable menopause-related and selected physiological outcomes. 

This is increasingly becoming a meaningful clinical research base.

What Does the Evidence Say About Maca and Menopause?

Maca also has randomized human research—but it is considerably older and smaller.

A systematic review identified four randomized clinical trials testing maca in perimenopausal or postmenopausal women.

All four reported favourable findings on at least some menopausal symptom measures.

However, the researchers concluded that the total number of participants, methodological quality and safety data were insufficient for firm conclusions.

The systematic review of maca for menopausal symptoms therefore described the evidence as limited, not definitive. 

One frequently cited trial included only 14 postmenopausal women.

They received 3.5 g/day of maca powder for six weeks and placebo for another six weeks in a crossover design.

Psychological symptoms and measures of sexual dysfunction improved with maca.

But serum estradiol, FSH, LH and sex hormone-binding globulin did not significantly change.

The 14-woman maca crossover trial is particularly useful because it challenges the simplistic statement that maca works by “balancing female hormones.” 

So Which Looks Better for Menopause?

Based on the current human literature, Shatavari now has the stronger case.

That is not because Ayurveda is inherently superior to Peruvian traditional medicine.

It is because Shatavari now has several larger and more recent placebo-controlled trials specifically examining menopausal and perimenopausal symptoms.

Maca's menopause evidence remains interesting, but the major systematic review is based on a small number of older trials.

This is a good example of why our recommendation should change when the evidence changes.

The WellBeingMora article on Shatavari for menopause and current human research goes deeper into these new trials rather than relying only on traditional-use claims.

Which Has Better Evidence for Libido?

This comparison has also shifted toward Shatavari.

A 2026 randomized, double-blind, placebo-controlled Indian trial enrolled 70 healthy women aged 18–45 who reported reduced sexual desire.

Participants received either 300 mg/day Shatavari root extract or placebo for eight weeks.

The primary outcome—the Female Sexual Function Index—improved significantly more with Shatavari. The between-group difference at day 56 was approximately 3.3 points, with favourable changes also reported in lubrication and several secondary wellbeing measures.

The 2026 Shatavari female-libido trial is currently one of the most directly relevant human studies for this question. 

Still, it is one trial.

It should not be converted into:

“Shatavari cures low libido.”

Sexual desire can be affected by relationships, medications, stress, vaginal pain, menopause, depression, sleep and many other factors.

Does Maca Help Libido?

Possibly.

Maca's reputation as a sexual-wellness herb does have some clinical support.

A systematic review of randomized trials found limited evidence suggesting maca could improve sexual function, but only four studies met inclusion criteria, participant numbers were small and methodological quality was insufficient for strong conclusions. PubMed

The 14-woman postmenopausal study discussed earlier reported improvements in sexual-dysfunction scores despite no meaningful changes in measured sex hormones. 

That observation is actually useful.

It suggests any possible effect of maca on sexual wellbeing does not need to come from “raising estrogen.”

So for libido:

Maca = plausible, preliminary evidence.

Shatavari = newer direct randomized evidence in women.

Which One “Balances Hormones”?

Neither should be marketed with such a vague promise.

“Hormonal balance” has no single laboratory definition.

A woman may have:

normal hormones but menopausal symptoms,

PCOS-related hyperandrogenism,

hypothyroidism,

elevated prolactin,

normal menstrual cycling,

or declining ovarian estrogen during menopause.

Calling all of those “hormonal imbalance” hides completely different physiology.

Some Shatavari trials have reported changes in selected hormone measurements, but those findings do not prove that Shatavari broadly normalizes female hormones.

Likewise, the maca crossover trial found symptom changes without significant changes in estradiol, FSH, LH or SHBG. 

So the customer-language answer should be:

Both herbs are marketed for women's hormonal wellness, but neither is clinically proven to universally “balance hormones.”

Which Is Better for Energy?

Neither has particularly strong evidence for ordinary everyday energy.

Shatavari's newer trials have reported improvements in fatigue or vitality as secondary outcomes in certain women.

For example, the recent perimenopause study reported improvement in fatigue-related measures, and the 2026 libido trial also found changes in fatigue scores. 

But those were not trials designed to show that healthy adults should take Shatavari as an energy supplement.

Maca is heavily marketed for “energy and stamina,” but much of this reputation comes from traditional use, small studies and athletic research rather than strong evidence in women with ordinary fatigue.

If a woman has persistent low energy, the more important questions may involve:

iron deficiency,

vitamin B12,

thyroid function,

sleep,

calorie/protein intake,

or another medical cause.

Choosing an “energy herb” first can distract from diagnosing the reason for the fatigue.

The Biggest Label Difference: Powder vs Extract

This is particularly important for WellBeingMora.

Most of the newer positive Shatavari trials used specific concentrated root extracts, often at doses around a few hundred milligrams daily.

That is not the same intervention as several grams of raw Shatavari root powder.

The WellBeingMora article explaining herbal extract vs raw herb powder explains why extract ratios and whole-herb grams cannot be automatically converted into clinical equivalence. 

Maca research is different again.

One of the best-known female studies used 3.5 g/day of powdered maca.

Therefore:

Shatavari extract research should not automatically be transferred to raw Shatavari powder.

Maca powder research should not automatically be transferred to an unspecified concentrated maca extract.

Evidence belongs to the actual preparation researchers studied.

Which Should You Choose?

For perimenopause or menopause, Shatavari currently has the more compelling and up-to-date human evidence.

For female sexual wellbeing, Shatavari again now has stronger recent direct research, although one trial is not enough to declare a definitive winner.

For energy, neither is strongly established.

For someone specifically drawn to maca as a food-style Andean root and willing to accept much older, more limited evidence, maca remains a reasonable research topic—but not a proven hormone treatment.

And if symptoms are severe enough to disrupt daily life, the important comparison is not Shatavari versus maca.

It is whether a botanical adjunct is appropriate alongside established menopause, endocrine or sexual-health care.

Where Does WellBeingMora Fit?

WellBeingMora currently offers raw Shatavari root powder, not the standardized 300 mg extract used in several of the newer clinical trials.

The WellBeingMora Shatavari Root Powder is a whole-root traditional format.

That distinction should remain explicit.

It would be incorrect to say that the WellBeingMora powder has been clinically proven to reproduce the outcomes from the recent standardized-extract studies.

For customers exploring women's nutritional and botanical support more broadly, the Women Wellness & Hormonal Balance collection contains the relevant WellBeingMora options. 

Safety and Who Should Be More Careful

Most published Shatavari and maca trials have been relatively short.

That means absence of major adverse events in an eight-week study is not the same as proving years of unrestricted use are safe.

Safety evidence is particularly limited for pregnancy and for people with complex hormone-sensitive conditions.

If menopausal symptoms include unexplained bleeding, severe pelvic symptoms or another change that has not been evaluated, using an herb should not substitute for finding the cause.

Similarly, low libido associated with pain, medication, depression or relationship problems requires a different approach from simply adding a botanical.

Bottom Line

The Shatavari vs maca comparison is no longer as even as it once was.

For menopause: Shatavari currently has the stronger and more recent human evidence.

For female libido: Shatavari now has a direct 2026 randomized trial, while maca's evidence remains promising but older and limited.

For energy: neither has sufficiently strong evidence to call it the clear winner.

For “hormone balancing”: neither deserves that blanket claim.

There is one final detail that matters enormously for WellBeingMora customers:

Most of the strongest new Shatavari studies use standardized extracts.

WellBeingMora currently sells a whole-root powder.

The correct message is therefore not:

“Clinical trials prove our Shatavari powder produces these results.”

It is:

“Shatavari as a botanical now has growing human research, while our product provides the traditional whole-root format.”

That distinction is more scientifically defensible—and ultimately more trustworthy.

Frequently Asked Questions

Q1. Is Shatavari better than maca for menopause?

Based on current evidence, Shatavari now has several newer randomized placebo-controlled trials and therefore has the stronger direct menopause research base.

Q2. Which is better for hot flashes?

Recent Shatavari trials have reported improvements in hot flashes compared with placebo. Maca studies also report menopausal symptom improvements, but the evidence is older and considerably smaller. PubMed

Q3. Which is better for libido?

Shatavari currently has stronger recent female-specific evidence, including a 2026 randomized trial of 70 women with reduced sexual desire. 

Q4. Does maca increase estrogen?

A small randomized crossover trial in postmenopausal women found symptom improvements without significant changes in estradiol, FSH, LH or SHBG.

Q5. Does Shatavari increase estrogen?

Some recent trials have reported changes in selected hormone measurements, but the evidence does not establish Shatavari as an estrogen replacement or a universal hormone-normalizing treatment.

Q6. Which is better for energy?

Neither has strong enough direct evidence to be considered a proven everyday energy supplement.

Q7. Can I take Shatavari and maca together?

There is little high-quality research establishing that combining them gives superior results. More ingredients do not automatically mean greater benefit.

Q8. Is Shatavari powder the same as Shatavari extract?

No. Raw root powder and standardized extract differ in concentration and serving size. Clinical-trial results should be applied to the form that was actually tested.

Q9. Can Shatavari replace menopause hormone therapy?

No. Current botanical trials are too small and short to establish Shatavari as an equivalent replacement for evidence-based menopausal hormone therapy when that therapy is medically appropriate.

Q10. Which would I choose if I wanted the herb with the strongest current women's research?

Based on the presently available direct human evidence for menopause and female sexual wellbeing, Shatavari has the stronger current research position. That conclusion refers to the botanical research overall, not proof that every Shatavari powder or extract produces identical results.